Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human TRIM37 Protein, N-His

Catalog #:   YHB50201 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: O94972
Protein length: Ser275-Ser405
Overview

Catalog No.

YHB50201

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ser275-Ser405

Predicted molecular weight

17.44 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

O94972

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

E3 ubiquitin-protein ligase TRIM37, 2.3.2.27, Mulibrey nanism protein, RING-type E3 ubiquitin transferase TRIM37, Tripartite motif-containing protein 37, TRIM37, KIAA0898, MUL, POB1

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Human TRIM37 protein
References

TRIM37 prevents ectopic spindle pole assembly by peptide motif recognition and substrate-dependent oligomerization., PMID:40415024

Mesoscale regulation of microtubule-organizing centers by the E3 ligase TRIM37., PMID:40415023

Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor., PMID:40378279

TMEM160 inhibits KEAP1 to suppress ferroptosis and induce chemoresistance in gastric cancer., PMID:40223081

Activation of TRIM37 by ATF6 and degradation of ACSL4: inhibiting ferroptosis and propelling cervical cancer progression., PMID:40158112

TRIM37 exacerbates cerebral ischemic injury by regulating the PPARγ/NF-κB pathway., PMID:39661528

The TRIM37 variant rs57141087 contributes to triple-negative breast cancer outcomes in Black women., PMID:39614126

Skeletal Phenotype in Mulibrey Nanism, A Monogenic Skeletal Dysplasia With Fibrous Dysplasia., PMID:39558672

Mesoscale regulation of MTOCs by the E3 ligase TRIM37., PMID:39416078

TRIM37 employs peptide motif recognition and substrate-dependent oligomerization to prevent ectopic spindle pole assembly., PMID:39416052

N6-methyladenosine-modified TRIM37 augments sunitinib resistance by promoting the ubiquitin-degradation of SmARCC2 and activating the Wnt signaling pathway in renal cell carcinoma., PMID:39349442

KIFC1 depends on TRIM37-mediated ubiquitination of PLK4 to promote centrosome amplification in endometrial cancer., PMID:39349439

Nanobubble-mediated co-delivery of siTRIM37 and IR780 for gene and sonodynamic combination therapy against triple negative breast cancer., PMID:39312939

TME-Responsive Nanoplatform with Glutathione Depletion for Enhanced Tumor-Specific Mild Photothermal/Gene/Ferroptosis Synergistic Therapy., PMID:39258005

Molecular similarities between the genes for Trypanosoma cruzi microtubule-associated proteins, mammalian interferons, and TRIMs., PMID:39251458

Mulibrey Nanism: A Case with Heart Failure., PMID:39225643

A proteomic study of the downregulation of TRIM37 on chondrocytes: Implications for the MULIBREY syndrome., PMID:39019132

TRIM37 interacts with EZH2 to epigenetically suppress PTCH1 and regulate stemness in glioma stem cells through sonic hedgehog pathway., PMID:38884661

LncRNA HOXC-AS3 accelerates malignant proliferation of cervical cancer cells via stabilizing KDM5B., PMID:38842683

TRIM37 is a primate-specific E3 ligase for Huntingtin and accounts for the striatal degeneration in Huntington's disease., PMID:38758800

TRIM27 Promotes Endothelial Progenitor Cell Apoptosis in Patients with In-Stent Restenosis by Ubiquitinating TBK1., PMID:38558276

Mulibrey nanism and immunological complications: a comprehensive case report and literature review., PMID:38116000

The role of hepatitis B virus surface protein in inducing Sertoli cell ferroptosis., PMID:37644905

Molecular characterization and functional analysis of TRIM37 from black tiger shrimp (Penaeus monodon)., PMID:37442309

A multi-platform normalization method for meta-analysis of gene expression data., PMID:37423473

Mechanisms of insertions at a DNA double-strand break., PMID:37402370

Discovery of the First Potent, Selective, and In Vivo Efficacious Polo-like Kinase 4 Proteolysis Targeting Chimera Degrader for the Treatment of TRIM37-Amplified Breast Cancer., PMID:37279162

TRIM37 exacerbates hepatic ischemia/reperfusion injury by facilitating IKKγ translocation., PMID:37158850

Downregulation of BASP1 Promotes Temozolomide Resistance in Gliomas via Epigenetic Activation of the FBXO32/NF-κB/MGMT Axis., PMID:36961398

Identifying genetic variants regulating MGMT gene expression - A study in monozygotic Danish twins., PMID:36948276

Whole Exome Sequencing Identified the Causative Mutation in a 4-Year-Old Female with Mulibrey Nanism: A Case Report., PMID:36742244

Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37., PMID:36252649

lncRNA NUTM2A-AS1 Targets the SRSF1/Trim37 Signaling Pathway to Promote the Proliferation and Invasion of Breast Cancer., PMID:35959349

Metformin inhibits the proliferation and invasion of ovarian cancer cells by suppressing tripartite motif-containing 37-induced tumor necrosis factor receptor-associated factor 2 ubiquitination., PMID:35950370

TRIM37 promotes the aggressiveness of ovarian cancer cells and increases c-Myc expression by binding to HUWE1., PMID:35921902

TRIM37 Augments AP-2γ Transcriptional Activity and Cellular Localization via K63-linked Ubiquitination to Drive Breast Cancer Progression., PMID:35864973

PBK drives PARP inhibitor resistance through the TRIM37/NFκB axis in ovarian cancer., PMID:35859118

Global cellular response to chemical perturbation of PLK4 activity and abnormal centrosome number., PMID:35758262

Design, synthesis, and biological evaluation of novel pyrazolo [3,4-d]pyrimidine derivatives as potent PLK4 inhibitors for the treatment of TRIM37-amplified breast cancer., PMID:35576702

Mechanism of RNA-binding protein Lin28 in neuronal ferroptosis after intracerebral haemorrhage., PMID:35359144

Modified Yuejuwan Inhibited Cholesterol Accumulation and Inflammation in THP-1 Macrophage-Derived Foam Cells by Inhibiting the Activity of the TRIM37/TRAF2/NF-κB Pathway., PMID:35310029

Liver pathology and biochemistry in patients with mutations in TRIM37 gene (Mulibrey nanism)., PMID:35220664

Identification Prognostic Value and Correlation with Tumor-Infiltrating Immune Cells of Tripartite-Motif Family Genes in Hepatocellular Carcinoma., PMID:35173473

TRIM37 Promotes Pancreatic Cancer Progression through Modulation of Cell Growth, Migration, Invasion, and Tumor Immune Microenvironment., PMID:35163097

Comprehensive profiling of the TRIpartite motif family to identify pivot genes in hepatocellular carcinoma., PMID:35142083

The protective effect of Metformin/Donepezil in diabetic mice brain: evidence from bioinformatics analysis and experiments., PMID:34982428

miR-942-5p prevents sepsis-induced acute lung injury via targeting TRIM37., PMID:34716956

TRIM37: a critical orchestrator of centrosome function., PMID:34672905

Increased alveolar epithelial TRAF6 via autophagy-dependent TRIM37 degradation mediates particulate matter-induced lung metastasis., PMID:34524943

Variants in 46,XY DSD-Related Genes in Syndromic and Non-Syndromic Small for Gestational Age Children with Hypospadias., PMID:34518484

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human TRIM37 Protein, N-His [YHB50201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only